2021
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry
Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. American Journal Of Psychiatry 2021, 179: 98-109. PMID: 34875873, DOI: 10.1176/appi.ajp.2021.21030320.Peer-Reviewed Original ResearchConceptsPsychiatric disordersRandomized double-blind placebo-controlled trialDouble-blind placebo-controlled trialTherapeutic useEvidence basePlacebo-controlled trialManagement of painBenefits of cannabisSearch of PubMedMental health cliniciansCurrent evidence basePotential side effectsSpecific medical conditionsPsychiatric indicationsFDA indicationClinical trialsHealth cliniciansMedical conditionsReference listsSide effectsChronic cannabisPsychotic disordersDrug AdministrationAdditional articlesMedicinal cannabis
2012
The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans
Skosnik PD, D'Souza DC, Steinmetz AB, Edwards CR, Vollmer JM, Hetrick WP, O'Donnell BF. The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans. Neuropsychopharmacology 2012, 37: 2184-2193. PMID: 22713908, PMCID: PMC3422484, DOI: 10.1038/npp.2012.65.Peer-Reviewed Original ResearchConceptsNeural oscillationsAuditory steady-state responseCannabis usersCannabis groupGamma rangeChronic cannabis usersCentral cannabinoid-1 receptorsCognitive processesTransient ERPsChronic cannabisChronic cannabinoidsHz powerEEG dataCurrent studyEffects of cannabinoidsCannabisPsychopharmacological effectsExogenous cannabinoidsNaïve controlsElectroencephalographySpectral powerTrial powerEarly ageX frequencyERP
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply